Analytical Data
-
基因名
C22orf31
- Application
-
别名
C22orf31Uncharacterized Protein C22orf31
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O95567
-
表达区间
1-290aa
-
氨基酸序列
MHPINVRRDPSIPIYGLRQSILLNTRLQDCYVDSPALTNIWMARTCAKQNINAPAPATTSSWEVVRNPLIASSFSLVKLVLRRQLKNKCCPPPCKFGEGKLSKRLKHKDDSVMKATQQARKRNFISSKSKQPAGHRRPAGGIRESKESSKEKKLTVRQDLEDRYAEHVAATQALPQDSGTAAWKGRVLLPETQKRQQLSEDTLTIHGLPTEGYQALYHAVVEPMLWNPSGTPKRYSLELGKAIKQKLWEALCSQGAISEGAQRDRFPGRKQPGVHEEPVLKKWPKLKSKK
-
分子量
59.1 KDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C22orf31, a protein encoded by the C22orf31 gene, has garnered attention in recent studies related to its potential roles in cellular processes and human diseases. This protein's exact biological function remains largely unexplored, but preliminary research suggests it may be involved in critical cellular pathways, including those related to cell proliferation and apoptosis. Mutations or dysregulation of C22orf31 have been implicated in certain genetic conditions, prompting further investigation into its structure and function. The recombinant expression of C22orf31 provides a valuable tool for elucidating its function and interactions within the cell. By producing and purifying this protein, researchers aim to characterize its biochemical properties, assess its role in various cellular contexts, and explore its potential as a biomarker or therapeutic target. The ongoing research into C22orf31 is vital not only for understanding fundamental biological processes but also for advancing the knowledge of its implications in human health and disease. Researchers are employing techniques such as crystallography and mass spectrometry to gain insights into the protein's structure and interactions, which may ultimately lead to the identification of novel therapeutic strategies for conditions associated with C22orf31 dysfunction. Overall, the investigation of C22orf31 as a recombinant protein represents a promising frontier in molecular biology and genetics, with implications for both basic science and translational medicine.












